Market Cap
$1.1B
FMC
FMC CORP
$8.52 ▼ -0.41%
Prev close $8.56Market cap$1.1B
ConsensusSell
12-mo target$13.58 (+59.2%)
▼ Bearish
Analyst conviction 3/10
33 New Institutional Positions17 Institutional ExitsCongressional Activity (1) Materials & Mining
Snapshot
The big-picture read on FMC right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Hold (33%)
Inst. Holders
50 funds
Inst. Value
$1.2B
Inst. Activity
33 buys / 17 sells
Insider Activity
$249.9K buy / $16.0K sell
Insider Net $
$234.0K
SEC Reports
11
Press Releases
1
Congressional
1 trades
Price chart 30d -36.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: FMC — 63.6% short (2.1M / 3.3M)
Short: 2,091,999 | Exempt: 8,659 | TRF Vol: 3,289,304 | Short Ratio: 63.6% | Off-exchange volume (da
Sep 28, 2026 Insider
Scanlan Jacqueline surrendered for taxes 5,137 shares
Executive VP & Chief HRO @ $9.58 ($49.2K)
Sep 9, 2026 Insider
Pfeiffer Nicholas sold 1,251 shares
Corporate Controller @ $12.78 ($16.0K)
Sep 2, 2026 Event
Jul 23, 2026 Press Statement Regarding Fairfield Medical Center’s Sale to Adena Health
On Sept. 1, 2026, Adena Health announced its acquisition of Fairfield Medical Center (FMC), a hospit
FMC Corporation declared a regular quarterly dividend of $0.08 per share, payable on October 15, 2026. This is a routine
Impact 2/10
Jul 16, 2026 Insider
BARRY MICHAEL F was granted 11 shares
Director
Jul 10, 2026 Congress
Jul 1, 2026 SEC Dan Newhouse sell
$1,001 - $15,000 — House
FMC entered into a stock purchase agreement with Tessenderlo Group NV for a ~$400M minority equity investment at $13.30/
8-K — Impact 6/10
Analyst ratings buy % +3.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
33% rate it Buy or better · 21 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 11, 2026 | Keybanc | INITIATE | Overweight | 52% |
| Aug 3, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Jul 31, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 31, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Jul 31, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | 55% |
| Jul 27, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Jul 21, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Jun 22, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| May 1, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| May 1, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 5 | 12 | 2 | 0 | 33% | |
| Aug 1, 2026 | 2 | 5 | 11 | 2 | 0 | 35% | |
| Jul 1, 2026 | 2 | 5 | 14 | 1 | 0 | 32% | |
| Jun 1, 2026 | 2 | 5 | 14 | 1 | 0 | 32% | |
| May 1, 2026 | 3 | 5 | 14 | 1 | 0 | 35% | |
| Apr 1, 2026 | 3 | 5 | 14 | 1 | 1 | 33% | |
| Mar 1, 2026 | 3 | 5 | 14 | 1 | 1 | 33% | |
| Feb 1, 2026 | 3 | 5 | 15 | 1 | 1 | 32% |
Price targets
Where 16 covering analysts think FMC trades over the next 12 months.
$13.58 +59.2% upside Strong Buy
Current$8.53 Low$11.00 Median$12.00 High$21.00 16 analysts
$11.00$21.00
Analyst rating Buy· 2.5/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
11 SEC filing reports analyzed · 1 bullish, 1 bearish, 4 mixed, 5 neutral · avg impact 4.4/10.Plus 1 press releases.
BULLISH8-K6/10
FMC entered into a stock purchase agreement with Tessenderlo Group NV for a ~$400M minority equity i
Jul 1, 2026
NEUTRAL8-K4/10
FMC entered Amendment No. 7 to its credit agreement to facilitate a $200M supply and license deal wi
Jun 24, 2026
MIXEDINST-CLUSTER5/10
A mixed institutional cluster in FMC during Q3 2024 shows 19 buyers accumulating $99.9M net (led by
Jun 12, 2026
NEUTRAL8-K4/10
FMC Corp. completed a private offering of $1.2 billion in aggregate principal amount of 8.000% Senio
Jun 5, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: FMC — 63.6% short (2.1M / 3.3M)
Short: 2,091,999 | Exempt: 8,659 | TRF Vol: 3,289,304 | Short Ratio: 63.6% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: FMC — 57.1% short (1.3M / 2.2M)
Short: 1,262,472 | Exempt: 744 | TRF Vol: 2,211,532 | Short Ratio: 57.1% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: FMC — 66.0% short (0.9M / 1.3M)
Short: 879,561 | Exempt: 618 | TRF Vol: 1,332,774 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
other
FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans PHILADELPHI
Sep 28, 2026
short_volume
Short Volume: FMC — 77.0% short (1.4M / 1.8M)
Short: 1,400,999 | Exempt: 866 | TRF Vol: 1,820,280 | Short Ratio: 77.0% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.11 | $0.03–$0.26 | -88.1% | -4.3% | 0↑ 12↓ | $0.9B | 15 |
| Next Q | $1.09 | $0.96–$1.21 | -9.5% | -0.0% | 8↑ 4↓ | $1.1B | 15 |
| Current FY | $1.28 | $1.09–$1.46 | -56.6% | -0.6% | 0↑ 13↓ | $3.6B | 16 |
| Next FY | $1.61 | $1.10–$2.16 | 25.8% | -1.7% | 1↑ 14↓ | $3.7B | 17 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.106 | — |
| 7d ago | $0.110 | -0.004 |
| 30d ago | $0.110 | -0.005 |
| 60d ago | $0.183 | -0.077 |
| 90d ago | $0.642 | -0.536 |
Institutional ownership
Which big funds own FMC (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.2B total value (106,893,346 shares) as of 2026-Q2. Top holders: BlackRock,, AQR, VANGUARD. Net buying activity: 33 institutions added/increased vs 17 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 21,535,604 | $247.7M | 20.1% | — |
| AQR CAPITAL MANAGEMENT LLC | 8,021,709 | $91.1M | 7.4% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,719,466 | $88.8M | 7.2% | — |
| STATE STREET CORP | 6,508,595 | $75.4M | 6.1% | ADD +35.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,758,841 | $66.2M | 5.4% | — |
| AMERICAN CENTURY COMPANIES INC | 5,053,535 | $58.1M | 4.7% | DOUBLED +139.1% |
| D. E. Shaw & Co., Inc. | 4,909,310 | $56.5M | 4.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 3,277,365 | $37.7M | 3.1% | ADD +56.0% |
| TWO SIGMA INVESTMENTS, LP | 2,829,728 | $32.5M | 2.6% | — |
| UBS Group AG | 2,522,414 | $29.0M | 2.4% | ADD +94.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| STATE STREET CORP | ADD | 4,800,031 | 6,508,595 | +35.6% | $75.4M |
| AMERICAN CENTURY COMPANIES INC | DOUBLED | 2,113,837 | 5,053,535 | +139.1% | $58.1M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 2,101,346 | 3,277,365 | +56.0% | $37.7M |
| UBS Group AG | ADD | 1,298,719 | 2,522,414 | +94.2% | $29.0M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | ADD | 1,232,686 | 2,218,590 | +80.0% | $25.5M |
| MORGAN STANLEY | TRIM | 3,399,801 | 2,120,151 | -37.6% | $24.4M |
| JPMORGAN CHASE & CO | DOUBLED | 195,096 | 2,046,103 | +948.8% | $23.7M |
| GOLDMAN SACHS GROUP INC | ADD | 1,500,006 | 1,940,452 | +29.4% | $22.3M |
| MARSHALL WACE, LLP | DOUBLED | 694,681 | 1,886,883 | +171.6% | $21.7M |
| NORTHERN TRUST CORP | ADD | 996,056 | 1,380,758 | +38.6% | $15.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
19 insiders, 50 transactions. Net $234.0K — $249.9K bought, $16.0K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Scanlan Jacqueline | Executive VP & Chief HRO | TAX W/H | 5,137 | $9.58 | $49.2K |
| Sep 9, 2026 | Pfeiffer Nicholas | Corporate Controller | SELL | 1,251 | $12.78 | $16.0K |
| Jul 16, 2026 | BARRY MICHAEL F | Director | AWARD | 11 | — | — |
| Jul 16, 2026 | BRONDEAU PIERRE R | Chairman, CEO and President | AWARD | 44 | — | — |
| Jul 16, 2026 | DAVIDSON CAROL ANTHONY | Director | AWARD | 83 | — | — |
| Jul 16, 2026 | Fortmann Kathy Lynn | Director | AWARD | 101 | — | — |
| Jul 16, 2026 | Verduin Patricia | Director | AWARD | 50 | — | — |
| Jul 16, 2026 | Johnson KLynne | Director | AWARD | 184 | — | — |
| Jul 16, 2026 | MERKT STEVEN T | Director | AWARD | 41 | — | — |
| Jul 16, 2026 | CORDEIRO EDUARDO E | Director | AWARD | 131 | — | — |
Congressional trades
FMC trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Dan Newhouse | R | HOUSE | SELL | $1,001 - $15,000 | FMC Corp | Jul 20, 2026(11d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for FMC.
Shares short
26,746,756
Settlement Sep 15, 2026
Change vs prior
-9.5%
Semi-monthly cycle
Days to cover
8.1
At avg daily volume
Of shares outstanding
≈21.4%
Estimate — not % of float
All FMC filing & press-release reports (12)
- PRESS-RELEASE reportJul 23, 2026
- 8-K reportJul 1, 2026
- 8-K reportJun 24, 2026
- INST-CLUSTER reportJun 12, 2026
- 8-K reportJun 5, 2026
- 8-K reportMay 21, 2026
- 8-K reportMay 19, 2026
- 8-K reportApr 29, 2026
- 8-K reportApr 29, 2026
- DEFA14A reportApr 27, 2026
- 8-K reportApr 20, 2026
- DEFA14A reportMar 13, 2026